Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ontera Bio

Ontera Bio
2011 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Grant LATEST DEAL TYPE
$2.8M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a digital, hand-held and single molecule biosensor designed to detect any kind of molecule with high sensitivity. The company's products include a point-of-use testing device that works like a glucose monitor, though its disposable test strips and is based on its core technology which includes solid-state, nanopore-based sensors that can detect nucleic acids and proteins and other analytes in human, animal, agriculture and environmental samples, enabling clients to perform digital, single-molecule sensing in a small, inexpensive and simple-to-use form factor in telemedicine.

Website
Formerly Known As
Two Pore Guys
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • 2161 Delaware Ave
  • Suite B
  • Santa Cruz, CA 95060
  • United States

+1 (831) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ontera Bio’s full profile, request a free trial.

Ontera Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 19-Nov-2018 $2.8M 000.00 Completed Product Development
5. Later Stage VC (Series A1) 09-Oct-2018 00.000 000.00 000.00 Completed Product Development
4. Later Stage VC (Series A2) 20-Sep-2018 00.00 0000 000.00 Completed Product Development
3. Later Stage VC (Series A) 25-Apr-2017 000.00 000.00 00000 Completed Product Development
2. Seed Round 05-Jul-2016 $7M $7M 0000 Completed Startup
1. Grant 01-Jan-2013 $150K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ontera Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 0.00
Seed 584,263 $0.000100 8% $19.13 $19.13 1x $19.13 9.68%
To view this company’s complete Cap Table, request access »

Ontera Bio Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Singulex Venture Capital-Backed Alameda, CA 000 00000 000000000 00000
000000000 Formerly VC-backed Fremont, CA 000 000.00 000000&0 000.00
000000000 Venture Capital-Backed Concon, Chile 00 00.000 0000000000 0 00.000
000000 Formerly VC-backed Billerica, MA 0000 00000 00000000 00000
000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

Ontera Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Applied Ventures Corporate Venture Capital Minority 000 0000 000000 0
Maxim Ventures Corporate Venture Capital Minority 000 0000 000000 0
DEFTA Partners Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ontera Bio Executive Team (6)

Name Title Board
Seat
Contact
Info
Murielle McLane Chief Executive Officer
William Dunbar Ph.D Co-Founder, Board Member & Chief Technology Officer
Gary Heffernan Executive
Dan Heller Co-Founder & Board Member

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Ontera Bio Board Members (2)

Name Representing Role Since Contact
Info
Dan Heller Ontera Bio Co-Founder & Board Member 000 0000
Vijit Sabnis Ph.D Khosla Ventures Board Member 000 0000